Retrospective Evaluation of Lung Adenocarcinoma Patients Progressing on 1st Line Chemotherapy
<i>Background and Objectives:</i> Evaluation of data from electronic health care records could help in guiding towards more rational drug treatments. This single center study evaluated clinical characteristics that could be associated with disease progression. <i>Methods:</i>...
Main Authors: | Heikki Vilhonen, Samu Kurki, Tarja Laitinen, Samuli Hirsjärvi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/11/743 |
Similar Items
-
A prognostic signature for lung adenocarcinoma by five genes associated with chemotherapy in lung adenocarcinoma
by: Xiaofeng Li, et al.
Published: (2023-12-01) -
Comparison of treatment strategies for resectable locally advanced primary mucinous adenocarcinoma of the lung
by: Yu Gu, et al.
Published: (2023-04-01) -
Limited Benefit from the Addition of Immunotherapy to Chemotherapy in TKI-Refractory EGFR-Mutant Lung Adenocarcinoma
by: Lingzhi Hong, et al.
Published: (2022-07-01) -
Impact of Different Treatment Regimens and Timeframes in the Plasmatic Metabolic Profiling of Patients with Lung Adenocarcinoma
by: Daniela Madama, et al.
Published: (2023-11-01) -
Lung Adenocarcinoma Cell Sensitivity to Chemotherapies: A Spotlight on Lipid Droplets and <i>SREBF1</i> Gene
by: Anna Ricarda Gründing, et al.
Published: (2022-09-01)